135 related articles for article (PubMed ID: 25872514)
1. Total score or subscales in scoring the acromegaly quality of life questionnaire: using novel confirmatory methods to compare scoring options.
Felt JM; Depaoli SA; Pereira AM; Biermasz NR; Tiemensma J
Eur J Endocrinol; 2015 Jul; 173(1):37-42. PubMed ID: 25872514
[TBL] [Abstract][Full Text] [Related]
2. Using subscales when scoring the Cushing's quality of life questionnaire.
Tiemensma J; Depaoli S; Felt JM
Eur J Endocrinol; 2016 Jan; 174(1):33-40. PubMed ID: 26431845
[TBL] [Abstract][Full Text] [Related]
3. Associations of remission status and lanreotide treatment with quality of life in patients with treated acromegaly.
Hua SC; Yan YH; Chang TC
Eur J Endocrinol; 2006 Dec; 155(6):831-7. PubMed ID: 17132752
[TBL] [Abstract][Full Text] [Related]
4. Quality of life (QOL) in patients with acromegaly is severely impaired: use of a novel measure of QOL: acromegaly quality of life questionnaire.
Rowles SV; Prieto L; Badia X; Shalet SM; Webb SM; Trainer PJ
J Clin Endocrinol Metab; 2005 Jun; 90(6):3337-41. PubMed ID: 15755865
[TBL] [Abstract][Full Text] [Related]
5. Impaired quality of life of patients with acromegaly: control of GH/IGF-I excess improves psychological subscale appearance.
Matta MP; Couture E; Cazals L; Vezzosi D; Bennet A; Caron P
Eur J Endocrinol; 2008 Mar; 158(3):305-10. PubMed ID: 18299462
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in acromegalic subjects: data from AcroBel, the Belgian registry on acromegaly.
T'Sjoen G; Bex M; Maiter D; Velkeniers B; Abs R
Eur J Endocrinol; 2007 Oct; 157(4):411-7. PubMed ID: 17893254
[TBL] [Abstract][Full Text] [Related]
7. Treatment of acromegaly improves quality of life, measured by AcroQol.
Paisley AN; Rowles SV; Roberts ME; Webb SM; Badia X; Prieto L; Shalet SM; Trainer PJ
Clin Endocrinol (Oxf); 2007 Sep; 67(3):358-62. PubMed ID: 17555502
[TBL] [Abstract][Full Text] [Related]
8. Validity and clinical applicability of the acromegaly quality of life questionnaire, AcroQoL: a 6-month prospective study.
Webb SM; Badia X; Surinach NL;
Eur J Endocrinol; 2006 Aug; 155(2):269-77. PubMed ID: 16868140
[TBL] [Abstract][Full Text] [Related]
9. Impaired quality of life in patients with treated acromegaly despite long-term biochemically stable disease: Results from a 5-years prospective study.
Kyriakakis N; Lynch J; Gilbey SG; Webb SM; Murray RD
Clin Endocrinol (Oxf); 2017 Jun; 86(6):806-815. PubMed ID: 28316090
[TBL] [Abstract][Full Text] [Related]
10. Assessment of quality of life in patients with uncontrolled vs. controlled acromegaly using the Acromegaly Quality of Life Questionnaire (AcroQoL).
Trepp R; Everts R; Stettler C; Fischli S; Allemann S; Webb SM; Christ ER
Clin Endocrinol (Oxf); 2005 Jul; 63(1):103-10. PubMed ID: 15963069
[TBL] [Abstract][Full Text] [Related]
11. The quality of life in acromegalic patients with biochemical remission by surgery alone is superior to that in those with pharmaceutical therapy without radiotherapy, using the newly developed Japanese version of the AcroQoL.
Yoshida K; Fukuoka H; Matsumoto R; Bando H; Suda K; Nishizawa H; Iguchi G; Ogawa W; Webb SM; Takahashi Y
Pituitary; 2015 Dec; 18(6):876-83. PubMed ID: 26123761
[TBL] [Abstract][Full Text] [Related]
12. Persistent negative illness perceptions despite long-term biochemical control of acromegaly: novel application of the drawing test.
Tiemensma J; Pereira AM; Romijn JA; Broadbent E; Biermasz NR; Kaptein AA
Eur J Endocrinol; 2015 May; 172(5):583-93. PubMed ID: 25724922
[TBL] [Abstract][Full Text] [Related]
13. Affected illness perceptions and the association with impaired quality of life in patients with long-term remission of acromegaly.
Tiemensma J; Kaptein AA; Pereira AM; Smit JW; Romijn JA; Biermasz NR
J Clin Endocrinol Metab; 2011 Nov; 96(11):3550-8. PubMed ID: 21917873
[TBL] [Abstract][Full Text] [Related]
14. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties.
Webb SM; Prieto L; Badia X; Albareda M; Catalá M; Gaztambide S; Lucas T; Páramo C; Picó A; Lucas A; Halperin I; Obiols G; Astorga R
Clin Endocrinol (Oxf); 2002 Aug; 57(2):251-8. PubMed ID: 12153605
[TBL] [Abstract][Full Text] [Related]
15. Short- and long-term changes of quality of life in patients with acromegaly: results from a prospective study.
Sardella C; Lombardi M; Rossi G; Cosci C; Brogioni S; Scattina I; Webb SM; Gasperi M; Martino E; Bogazzi F
J Endocrinol Invest; 2010 Jan; 33(1):20-5. PubMed ID: 20203538
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly Quality of Life Questionnaire (AcroQoL).
Badia X; Webb SM; Prieto L; Lara N
Health Qual Life Outcomes; 2004 Feb; 2():13. PubMed ID: 14987332
[TBL] [Abstract][Full Text] [Related]
17. Disease control and treatment modalities have impact on quality of life in acromegaly evaluated by Acromegaly Quality of Life (AcroQoL) Questionnaire.
Vandeva S; Yaneva M; Natchev E; Elenkova A; Kalinov K; Zacharieva S
Endocrine; 2015 Aug; 49(3):774-82. PubMed ID: 25561370
[TBL] [Abstract][Full Text] [Related]
18. Clinical osteoarthritis predicts physical and psychological QoL in acromegaly patients.
Wassenaar MJ; Biermasz NR; Kloppenburg M; van der Klaauw AA; Tiemensma J; Smit JW; Pereira AM; Roelfsema F; Kroon HM; Romijn JA
Growth Horm IGF Res; 2010 Jun; 20(3):226-33. PubMed ID: 20194043
[TBL] [Abstract][Full Text] [Related]
19. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly.
Roerink SH; Wagenmakers MA; Wessels JF; Sterenborg RB; Smit JW; Hermus AR; Netea-Maier RT
Pituitary; 2015 Jun; 18(3):366-75. PubMed ID: 24965695
[TBL] [Abstract][Full Text] [Related]
20. Mapping AcroQoL scores to EQ-5D to obtain utility values for patients with acromegaly.
Badia X; Trainer P; Biermasz NR; Tiemensma J; Carreño A; Roset M; Forsythe A; Webb SM
J Med Econ; 2018 Apr; 21(4):382-389. PubMed ID: 29261359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
